Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus

Progress in corticotropin-releasing factor-1 antagonist development

(2010) Eric P. Zorrilla et al.   DRUG DISCOVERY TODAY

Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions

(2010) Satoshi Yamamura et al.   NEUROPHARMACOLOGY

Role of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression

(2009) Richard L. Hauger et al.   Annals of the New York Academy of Sciences

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

(2009) Lakshmi N Yatham et al.   BIPOLAR DISORDERS

Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction

(2009) Rita J. Valentino et al.   BRAIN RESEARCH

Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex

(2009) S Yamamura et al.   BRITISH JOURNAL OF PHARMACOLOGY

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

(2009) John R. Geddes et al.   BRITISH JOURNAL OF PSYCHIATRY

Topiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin

(2009) Satoshi Yamamura et al.   EPILEPSY RESEARCH

Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway

(2009) S. Yamamura et al.   NEUROPHARMACOLOGY

Effects of zonisamide on neurotransmitter release associated with inositol triphosphate receptors

(2009) Satoshi Yamamura et al.   NEUROSCIENCE LETTERS

Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex

(2009) Satoshi Yamamura et al.   PSYCHOPHARMACOLOGY

A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH1Antagonist) in the Treatment of Major Depression

(2008) Brendon Binneman et al.   AMERICAN JOURNAL OF PSYCHIATRY

Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain

(2008) Irene Drizin et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Central CRH system in depression and anxiety — Evidence from clinical studies with CRH1 receptor antagonists

(2008) Florian Holsboer et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Pro- and Anti-Nociceptive Effects of Corticotropin-Releasing Factor (CRF) in Central Amygdala Neurons Are Mediated Through Different Receptors

(2008) Guangchen Ji et al.   JOURNAL OF NEUROPHYSIOLOGY

Rats Harboring S284L Chrna4 Mutation Show Attenuation of Synaptic and Extrasynaptic GABAergic Transmission and Exhibit the Nocturnal Frontal Lobe Epilepsy Phenotype

(2008) G. Zhu et al.   JOURNAL OF NEUROSCIENCE

The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin  -Opioid System

(2008) B. B. Land et al.   JOURNAL OF NEUROSCIENCE